These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 4047673)
1. Chemotherapy of head and neck cancer. Kies MS; Levitan N; Hong WK Otolaryngol Clin North Am; 1985 Aug; 18(3):533-41. PubMed ID: 4047673 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy in cancer of the head and neck. O'Donoghue GM; Hong WK Ir Med J; 1986 Jan; 79(1):20-3. PubMed ID: 2419276 [No Abstract] [Full Text] [Related]
3. Overview of platinum chemotherapy in head and neck cancer. Forastiere AA Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of head and neck cancer]. Kohno N; Nakazawa E; Kusunoki M; Nishiya M Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514 [TBL] [Abstract][Full Text] [Related]
6. Future directions in the chemotherapy of head and neck cancer. Grunberg SM Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435 [No Abstract] [Full Text] [Related]
7. Chemotherapy for squamous cell carcinoma of the head and neck: an overview. Espinola TE; White JA J La State Med Soc; 1990 Jul; 142(7):15-8. PubMed ID: 2204670 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of squamous cell carcinoma of the head and neck. Greenberg BR Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534 [No Abstract] [Full Text] [Related]
10. Cisplatin combinations in the treatment of head and neck cancer. al-Sarraf M Semin Oncol; 1994 Oct; 21(5 Suppl 12):28-34. PubMed ID: 7992064 [TBL] [Abstract][Full Text] [Related]
11. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in head and neck cancer. Hong WK; Bromer R N Engl J Med; 1983 Jan; 308(2):75-9. PubMed ID: 6183588 [No Abstract] [Full Text] [Related]
13. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
14. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901 [TBL] [Abstract][Full Text] [Related]
15. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience. Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552 [TBL] [Abstract][Full Text] [Related]
16. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007. Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH; Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372 [TBL] [Abstract][Full Text] [Related]
18. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy. Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309 [TBL] [Abstract][Full Text] [Related]
20. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck. Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]